Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database

BACKGROUND: The clinical characteristics of mTOR (mammalian target of rapamycin) inhibitors use in heart transplant recipients and their outcomes have not been well described. METHODS AND RESULTS: We compared patients who received mTOR inhibitors within the first 2 years after heart transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampaktsis, Polydoros N., Doulamis, Ilias P., Asleh, Rabea, Makri, Elpiniki, Kalamaras, Ilias, Papastergiopoulos, Christoforos, Emfietzoglou, Maria, Drosou, Anastasis, Van den Eynde, Jef, Alnsasra, Hilmi, Duque, Ernesto Ruiz, Briasoulis, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496402/
https://www.ncbi.nlm.nih.gov/pubmed/36000418
http://dx.doi.org/10.1161/JAHA.122.025507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496402/
https://www.ncbi.nlm.nih.gov/pubmed/36000418
http://dx.doi.org/10.1161/JAHA.122.025507

Ejemplares similares